Barclays analyst Jeffrey Bernstein lowered the firm’s price target on Cava Group (CAVA) to $74 from $91 and keeps an Equal Weight rating on the shares. The company’s Q2 disappointed on comp sales but still beat on margin and EBITDA, the analyst tells investors in a research note. The firm says that while Cava’s 2025 outlook was lowered for comp sales, it still calls for an acceleration on a two-year stack.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAVA:
- CAVA Group, Inc.: Strong Growth Potential and Financial Stability Support Buy Rating
- CAVA Group, Inc.: Strong Fundamentals Amid Sales Concerns and Valuation Challenges
- Cava Group price target lowered to $75 from $96 at UBS
- Optimistic Buy Rating for CAVA Group Despite Sales Challenges, Driven by Strong New Location Performance and EBITDA Exceedance
- CAVA Group Reports Strong Q2 2025 Financial Results